Literature DB >> 29288339

Cdk5 Contributes to Huntington's Disease Learning and Memory Deficits via Modulation of Brain Region-Specific Substrates.

Elena Alvarez-Periel1,2,3, Mar Puigdellívol1,2,3, Verónica Brito1,2,3, Florian Plattner4, James A Bibb5, Jordi Alberch1,2,3, Silvia Ginés6,7,8.   

Abstract

Cognitive deficits are a major hallmark of Huntington's disease (HD) with a great impact on the quality of patient's life. Gaining a better understanding of the molecular mechanisms underlying learning and memory impairments in HD is, therefore, of critical importance. Cdk5 is a proline-directed Ser/Thr kinase involved in the regulation of synaptic plasticity and memory processes that has been associated with several neurodegenerative disorders. In this study, we aim to investigate the role of Cdk5 in learning and memory impairments in HD using a novel animal model that expresses mutant huntingtin (mHtt) and has genetically reduced Cdk5 levels. Genetic reduction of Cdk5 in mHtt knock-in mice attenuated both corticostriatal learning deficits as well as hippocampal-dependent memory decline. Moreover, the molecular mechanisms by which Cdk5 counteracts the mHtt-induced learning and memory impairments appeared to be differentially regulated in a brain region-specific manner. While the corticostriatal learning deficits are attenuated through compensatory regulation of NR2B surface levels, the rescue of hippocampal-dependent memory was likely due to restoration of hippocampal dendritic spine density along with an increase in Rac1 activity. This work identifies Cdk5 as a critical contributor to mHtt-induced learning and memory deficits. Furthermore, we show that the Cdk5 downstream targets involved in memory and learning decline differ depending on the brain region analyzed suggesting that distinct Cdk5 effectors could be involved in cognitive impairments in HD.

Entities:  

Keywords:  Cdk5; Cognition; Dendritic spines; Huntingtin; NR2B; Rac1

Mesh:

Substances:

Year:  2017        PMID: 29288339     DOI: 10.1007/s12035-017-0828-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  72 in total

Review 1.  Presynaptic dysfunction in Huntington's disease.

Authors:  José L Rozas; Leonardo Gómez-Sánchez; Cristina Tomás-Zapico; José J Lucas; Rafael Fernández-Chacón
Journal:  Biochem Soc Trans       Date:  2010-04       Impact factor: 5.407

2.  Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity.

Authors:  A Giralt; M Puigdellívol; O Carretón; P Paoletti; J Valero; A Parra-Damas; C A Saura; J Alberch; S Ginés
Journal:  Hum Mol Genet       Date:  2011-11-24       Impact factor: 6.150

3.  Mild cognitive impairment in prediagnosed Huntington disease.

Authors:  K Duff; J Paulsen; J Mills; L J Beglinger; D J Moser; M M Smith; D Langbehn; J Stout; S Queller; D L Harrington
Journal:  Neurology       Date:  2010-07-07       Impact factor: 9.910

Review 4.  A decade of CDK5.

Authors:  R Dhavan; L H Tsai
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

5.  Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology.

Authors:  Yong Kim; Jee Young Sung; Ilaria Ceglia; Ko-Woon Lee; Jung-Hyuck Ahn; Jonathan M Halford; Amie M Kim; Seung P Kwak; Jong Bae Park; Sung Ho Ryu; Annette Schenck; Barbara Bardoni; John D Scott; Angus C Nairn; Paul Greengard
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

Review 6.  Recent advances in understanding the roles of Cdk5 in synaptic plasticity.

Authors:  Kwok-On Lai; Nancy Y Ip
Journal:  Biochim Biophys Acta       Date:  2009-05-13

7.  Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors.

Authors:  Jian Wang; ShuHong Liu; YangPing Fu; Jerry H Wang; YouMing Lu
Journal:  Nat Neurosci       Date:  2003-09-21       Impact factor: 24.884

8.  Regulation of Kalirin by Cdk5.

Authors:  Xiaonan Xin; Yanping Wang; Xin-ming Ma; Panteleimon Rompolas; Henry T Keutmann; Richard E Mains; Betty A Eipper
Journal:  J Cell Sci       Date:  2008-07-15       Impact factor: 5.285

9.  Suppression of mutant Huntingtin aggregate formation by Cdk5/p35 through the effect on microtubule stability.

Authors:  Sayuko Kaminosono; Taro Saito; Fumitaka Oyama; Toshio Ohshima; Akiko Asada; Yoshitaka Nagai; Nobuyuki Nukina; Shin-Ichi Hisanaga
Journal:  J Neurosci       Date:  2008-08-27       Impact factor: 6.167

10.  Evidence for specific cognitive deficits in preclinical Huntington's disease.

Authors:  A D Lawrence; J R Hodges; A E Rosser; A Kershaw; C ffrench-Constant; D C Rubinsztein; T W Robbins; B J Sahakian
Journal:  Brain       Date:  1998-07       Impact factor: 13.501

View more
  9 in total

1.  Computational Simulations Identified Two Candidate Inhibitors of Cdk5/p25 to Abrogate Tau-associated Neurological Disorders.

Authors:  Amir Zeb; Minky Son; Sanghwa Yoon; Ju Hyun Kim; Seok Ju Park; Keun Woo Lee
Journal:  Comput Struct Biotechnol J       Date:  2019-04-22       Impact factor: 7.271

Review 2.  Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications.

Authors:  Muhammet Oner; Eugene Lin; Mei-Chih Chen; Fu-Ning Hsu; G M Shazzad Hossain Prince; Kun-Yuan Chiu; Chieh-Lin Jerry Teng; Tsung-Ying Yang; Hsin-Yi Wang; Chia-Herng Yue; Ching-Han Yu; Chih-Ho Lai; Jer-Tsong Hsieh; Ho Lin
Journal:  Int J Mol Sci       Date:  2019-08-09       Impact factor: 5.923

3.  Case Report: Congenital Brain Dysplasia, Developmental Delay and Intellectual Disability in a Patient With a 7q35-7q36.3 Deletion.

Authors:  Liang-Liang Fan; Yue Sheng; Chen-Yu Wang; Ya-Li Li; Ji-Shi Liu
Journal:  Front Genet       Date:  2021-12-01       Impact factor: 4.599

Review 4.  The role of Cdk5 in neurological disorders.

Authors:  Chuncao Ao; Chenchen Li; Jinlun Chen; Jieqiong Tan; Liuwang Zeng
Journal:  Front Cell Neurosci       Date:  2022-07-28       Impact factor: 6.147

Review 5.  Protein Kinase CK2 and Its Potential Role as a Therapeutic Target in Huntington's Disease.

Authors:  Angel White; Anna McGlone; Rocio Gomez-Pastor
Journal:  Biomedicines       Date:  2022-08-15

6.  RTP801/REDD1 contributes to neuroinflammation severity and memory impairments in Alzheimer's disease.

Authors:  Albert Giralt; Cristina Malagelada; Leticia Pérez-Sisqués; Anna Sancho-Balsells; Júlia Solana-Balaguer; Genís Campoy-Campos; Marcel Vives-Isern; Ferran Soler-Palazón; Marta Anglada-Huguet; Miguel-Ángel López-Toledano; Eva-Maria Mandelkow; Jordi Alberch
Journal:  Cell Death Dis       Date:  2021-06-15       Impact factor: 8.469

7.  M2 cortex-dorsolateral striatum stimulation reverses motor symptoms and synaptic deficits in Huntington's disease.

Authors:  Sara Fernández-García; Sara Conde-Berriozabal; Esther García-García; Clara Gort-Paniello; David Bernal-Casas; Gerardo García-Díaz Barriga; Javier López-Gil; Emma Muñoz-Moreno; Guadalupe Soria; Leticia Campa; Francesc Artigas; Manuel José Rodríguez; Jordi Alberch; Mercè Masana
Journal:  Elife       Date:  2020-10-05       Impact factor: 8.140

8.  Neuron type-specific increase in lamin B1 contributes to nuclear dysfunction in Huntington's disease.

Authors:  Rafael Alcalá-Vida; Marta Garcia-Forn; Carla Castany-Pladevall; Jordi Creus-Muncunill; Yoko Ito; Enrique Blanco; Arantxa Golbano; Kilian Crespí-Vázquez; Aled Parry; Guy Slater; Shamith Samarajiwa; Sandra Peiró; Luciano Di Croce; Masashi Narita; Esther Pérez-Navarro
Journal:  EMBO Mol Med       Date:  2020-12-28       Impact factor: 14.260

Review 9.  When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease.

Authors:  Santosh R D'Mello
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.